On September 11, 2023, Aimed Alliance sent a letter to Centers for Medicare and Medicaid Services (CMS) commenting on CMS’s proposed rule addressing the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 (CMS-1793-P).
In response to the Supreme Court’s decision in American Hospital Association v. Becerra, which invalidated the reduction in prescription drug payment rates from CMS’s January 2017 rule on the 340B-acquired drug payment policy, CMS proposed a rule that would provide lump-sum payments to affected providers to rectify the underpayment related to the drug payment policy between 2018 and 2022. Aimed Alliance expressed support for this decision, highlighting the importance of alleviating the financial burdens faced by hospitals serving low-income patients. Furthermore, Aimed Alliance supported CMS’s commitment to preventing unexpected changes in cost sharing, particularly for low-income patients, by reimbursing hospitals for what they would have received from beneficiary cost-sharing. Read the comment here.
Last Updated on September 18, 2023 by Aimed Alliance
